UK based chemical development company offers stable retinoid derivatives with intrinsic fluorescence to partners interested in collaboration or licensing

Technology offer: UK based chemical development company offers stable retinoid derivatives with intrinsic fluorescence to partners interested in collaboration or licensing.

Reference: TOUK20140911001

Summary: An SME in the North East of England has developed a range of stable retinoid derivatives with intrinsic fluorescence. These are chemical compounds which control aspects of stem cell behaviour and can be used in biomedical research in the field of cell proliferation, differentiation and apoptosis (programmed cell death).

The company is looking for partners from the life sciences and biomedical sector who would like to collaborate or license the compounds.

For more information click here.

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.